Assessing disparities in cancer resources distribution in Mexico
Authors:
- Elysse Bautista-GonzalezElysse Bautista-Gonzalez
- Andrés Quintero LeyraALAndrés Quintero Leyra
- Teresa Verenice Munoz RochaTRTeresa Verenice Munoz Rocha
- Heber Tomás Reyes-GarcíaHRHeber Tomás Reyes-García
- Enrique Soto-Perez-De-CelisESEnrique Soto-Perez-De-Celis
- Alejandra Palafox ParrillaAPAlejandra Palafox Parrilla
- Alejandro Mohar BetancourtABAlejandro Mohar Betancourt
- Richard SullivanRSRichard Sullivan
Open Access
- 17 April 2025
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1-13
Abstract
Background: Given the rising cancer burden, the capacity of Mexico’s healthcare system to effectively address cancer care through its current available infrastructure becomes increasingly critical. Limited availability of diagnostic and therapeutic infrastructure leads to delays in diagnosis and treatment. Countries like Mexico, should undertake comprehensive assessments of infrastructure and human resources available for cancer, including its quantification and geolocation, to understand the service gaps. This study seeks to map oncological infrastructure in Mexico in five types of cancer: breast, lung, prostate, colon, and cervix. Methods: Through a realist evaluation of publicly available databases from the High Specialty Medical Equipment National Inventory and the General Direction of Health Information, a comprehensive identification and classification of cancer resources was conducted with the intended outcome to map cancer care infrastructure in Mexico. Guided by the literature, resources necessary for diagnosis and treatment were selected by an expert consensus. Thereafter, facilities were classified by service scope into either diagnostic or diagnostic and therapeutic, and by infrastructure level into core or enhanced and then mapped geographically. Results: From N = 14,133 unique healthcare facilities that deliver any type of healthcare, only 5% provided cancer care. Cancer-specific infrastructure that can provide diagnosis and treatment at the national level included N = 10 brachytherapy, N = 11 cobalt-60, N = 21 linear particle accelerators and N = 188 operating rooms. Five issues were found: (1) low availability of core therapeutic infrastructure across all cancer types; (2) regional and national centralization of available therapeutic infrastructure for all cancer types, whilst no centralization found in diagnostic resources; (3) inconsistent allocation of resources in densely populated areas; (4) infrastructure disparities per cancer type i.e., Lung, prostate, and breast cancer require significant investments in diagnostic infrastructure compared to cervical and colon cancer, and (5) lack of precise and updated infrastructure data from the public health system that requires either new codes or subcodes. Conclusions: Addressing disparities in cancer resources distribution in Mexico is a dual imperative—ensuring equity while seizing an opportunity to fortify the overall health system for people without social security coverage.Keywords
Funding Information
- Fundación Mexicana para la Salud
This publication has 55 references indexed in Scilit:
- Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruptionThe Lancet, 2023
- Distribution of the workforce involved in cancer care: a systematic review of the literatureESMO Open, 2021
- Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forwardThe Lancet Oncology, 2021
- Reducing waiting time for remote patients in telemedicine with considering treated patients in emergency department based on body sensors technologies and hybrid computational algorithms: Toward scalable and efficient real time healthcare monitoring systemJournal of Biomedical Informatics, 2020
- Health System in Mexico2019
- The Diagnosis and Treatment of Prostate CancerJAMA, 2017
- Participants' barriers to diagnostic resolution and factors associated with needing patient navigationCancer, 2015
- Health system delay and its effect on clinical stage of breast cancer: Multicenter studyCancer, 2015
- Planning cancer control in Latin America and the CaribbeanThe Lancet Oncology, 2013
- Breast cancer in Mexico: a growing challenge to health and the health systemThe Lancet Oncology, 2012